English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

A new chiral chromatography method has been developed to determine the chiral purity of MB-102. This method employs exchange of counter ions with the MB-102 molecule. Chromatography conditions including column temperature and concentration of counter ions were evaluated and optimized. This method may be used to monitor process development during formulation manufacture, is amenable to large scale production, and is suitable for the determination of agent chirality for reporting in regulatory submissions. Manufactured clinical supplies of both the drug substance and the drug product using this technique have been shown to routinely yield 99.9+ % D, D enantiomer. This new method is shown to be precise, accurate, and robust.

analytical letters

Novel Chiral High-Performance Liquid Chromatographic (HPLC) Determination of MB-102, A New Fluorescent Tracer Agent Enabling the Measurement of Point-of-Care Glomerular Filtration Rate